stockrowLantheus Holdings, Inc.
LNTH Healthcare Drug Manufacturers Specialty & Generic
Lantheus Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 0.50% from fiscal 2024.
- Revenue
- +1.54%
- EPS
- −17.1%
- Free cash flow
- +7.71%
- Total debt
- +0.52%
Quarter to September 2026, against a year earlier
Follow LNTH
Alert me
Lantheus Holdings, Inc. (LNTH) Operating cash flow
Lantheus Holdings, Inc.'s operating cash flow for fiscal 2025 was $390.1M, down 28.4% from $544.8M in fiscal 2024. Over the twelve months to 30 September 2026 it was $409.5M. Over the past ten years it has ranged from $16.4M (fiscal 2020) to $544.8M (fiscal 2024); the current reading is higher than 91% of that period. Lantheus Holdings, Inc. ranks 9th of 84 Drug Manufacturers Specialty & Generic companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $390.1M | (28.38%) |
| FY2024 | $544.8M | 78.45% |
| FY2023 | $305.3M | 8.33% |
| FY2022 | $281.8M | 422.63% |
| FY2021 | $53.9M | 228.84% |
| FY2020 | $16.4M | (79.60%) |
| FY2019 | $80.4M | 31.36% |
| FY2018 | $61.2M | 11.71% |
| FY2017 | $54.8M | 10.34% |
| FY2016 | $49.6M | 128.11% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $102.0M | 10.60% |
| Jun 2026 | $92.2M | (26.31%) |
| Mar 2026 | $125.1M | 38.76% |
| Dec 2025 | $90.2M | (14.36%) |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| LNTH Lantheus Holdings, Inc. | $409.5M |
| RDY Dr. Reddy's Laboratories Ltd compare | $313.0M |
| HIMS Hims & Hers Health, Inc. compare | $263.5M |
| ALKS Alkermes plc compare | $243.0M |
| KNSA Kiniksa Pharmaceuticals International, plc compare | $198.8M |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | $180.6M |
| LQDA Liquidia Corporation compare | $167.7M |
| SUPN Indivior Pharmaceuticals Inc. compare | $96.0M |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −$126.6M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on LNTH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement